Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
DiogenX Raises €27.5M Series A Financing to Advance its First-In-Class Treatment for Type 1 Diabetes
DiogenX, a biotech company focused on regenerating insulin-producing beta cells for the treatment of diabetes, […]
Sobi to Acquire CTI BioPharma
CTI BioPharma, a commercial biopharmaceutical company focused on the development and commercialization of novel targeted […]
Interius BioTherapeutics Announces Successful Manufacturing Partnership with WuXi Advanced Therapies
Interius BioTherapeutics, a preclinical stage gene therapy company developing novel methods for in vivo cell-specific […]
Vicinitas Therapeutics Appoints Christian Hofmann, Ph.D., as Chief Executive Officer
Vicinitas Therapeutics, a biotechnology company advancing a proprietary targeted protein stabilization platform to develop novel […]
Maryland Stem Cell Research Commission Announces Over $14 Million in Awards to Accelerate Stem Cell Cures
The Maryland Stem Cell Research Commission is pleased to announce over $14.1 million in grant […]
Nutcracker Therapeutics Appoints Cynthia Collins, Biopharma Veteran and Former Editas Medicine CEO, to Board of Directors
Nutcracker Therapeutics, a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology […]
CytoMed Therapeutics Announces Collaboration with MD Anderson Cancer Center
CytoMed Therapeutics, a biopharmaceutical company focused on harnessing its licensed proprietary technologies to create novel […]
Katerina Evangeli, Pro-Lab Diagnostics, on New Diagnostic Products and Technologies
In this interview, Katerina Evangeli, Territory Manager at Pro-Lab Diagnostics, discussed her company’s new Diagnostic […]
Lyndra Therapeutics Doses First Clinical Trial Participant in Pivotal Study of Oral Weekly Risperidone (LYN-005) for Schizophrenia and Schizoaffective Disorder
Lyndra Therapeutics, a clinical-stage biopharmaceutical company working to make daily pills a thing of the […]
FDA Accepts Application for Roche’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)
Roche has announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more